Facebook Inc. took a momentous action last week. And I don’t mean its announced intention to sell shares for $28 to $35 in an initial public offering later this month.

Altruism is simply not enough to satisfy the global organ shortage that has spawned illegal and unregulated organ markets, so government-sponsored compensation of healthy of individuals who are willing to give one of their kidneys is the best short-term solution.

This year, more than 100,000 Americans will be diagnosed with a potentially deadly blood disease. Among those in need of lifesaving, blood-producing marrow cells, thousands will die because it is so difficult to find a nearly perfect genetic match and marrow donors are in short supply.

Material incentives, from tax credits...

Israel should be commended for its two-pronged approach to its organ problem: incentives and efforts to combat trafficking.

To help remedy the organ shortage, the District of Columbia should pass a law enabling donors to receive benefits for their sacrifice.

In the recent case of Abigail Alliance v. von Eschenbach, a divided panel of the United States Court of Appeals for the D.C. Circuit held that the due process clause required the Food and Drug Administration (FDA) to allow terminally ill patients the opportunity to use last-hope drugs that have...

It is time for a state to challenge the 1984 National Organ Transplant Act and offer funeral benefits or some other reward to the estate of those who will give their organs at death.

Sally Satel assembles medical practitioners, legal scholars, economists, and ethicists to evaluate the merits of and need for an incentive-based system for increasing the supply of kidneys.